人们生存或死亡，因为这个小字眼。
生存或死亡，是一个问题。
但是现在我们感到非常失望。你们能够给我们一个回答吗？生存或死亡。
But now we feel disappointed. Would you like to give us an answer? LIFE OR DEATH.
生存或死亡的意识在她的诗中涌动着，成为我们阐释理解其诗歌艺术的切入点。
The consciousness of "to be or not to be", which vibrates in her poems, then becomes a key to the interpretation of her poetic art for us.
澳大利亚人被警告由于水他们面对生存或死亡的抉择- - -要么喝循环的污水或者死亡。
Australians have been warned they face a life or death decision over their water-drink recycled sewage or die.
有些目标可以说就意味着生存或死亡。目前，每年能活到五岁以上的儿童已经超过了300万，但不能活到这个年龄的儿童有1000万。
Some targets are literally a matter of life or death: there are now 3 million more children who survive past the age of five, but there are 10 million children a year who don't.
在我把我的第一篇小说《生存或死亡》给您之后，和我小说平时得到的看法一样，您说您感到有点“心烦意乱”，但我还是很喜欢。
I also liked it when after I sent you my first novel - Life or Death, and you said you were a bit "squeamish" that is a common reply to my novel.
每一个产品的成功或失败关系着我们的生存和死亡。
We lived and died with each piece of news of our product's success or failure.
接收激进手术治疗的病人身体变型更大，也更容易受到附属疾病的困扰，但是慕克吉写道他们“在生存率、复发率或死亡率上却没有得到任何好处。”
The latter group paid heavily in disfigurement and ancillary ill health, but, Mukherjee writes, they “accrued no benefits in survival, recurrence, or mortality.”
人们通常不会考虑到影响极移后生活的一些变数，如某些被看好的作物或动物竟然生存困难或干脆死亡，而另外一些却生机勃勃。
There are variables mankind does not normally consider that will be affecting life after the shift, such that an assumed plant or animal life would falter and simply die off, and others flourish.
报纸，杂志，音乐，电视，电影——所有传统模式都在死亡或趋近死亡，就像浑身是血的大人物四处爬行为求生存那般。
Newspapers, magazines, music, television, movies - all of the traditional models are dead or dying as bloodied moguls everywhere scramble to survive.
生存期（从病人诊断到死亡或末次随访时间）2-144个月，平均生存时间50.93个月。
The survival time (from diagnosis to dead or last investigation) was 2-144 month. The mean survival time is 50.93 month.
要发育成记忆细胞，B细胞必须在细胞凋亡或程序性细胞死亡这一自然过程中生存下来，细胞凋亡则随着明显的免疫响应而出现。
To develop into memory cells, B cells have to survive the natural process of apoptosis, or programmed cell death, that occurs following a large immune response.
在上帝的见证下，奉你为我唯一的人生伴侣。此后无论好或坏，富有贫穷，无论疾病健康，永远珍惜爱护你，从生存之陆地直到天堂。并且承诺对你忠诚，直到死亡将彼此分离。
To have and to hold, from this day forward, for better, for worse, for richer, for poorer, in sickness and in health, to love and to cherish, till death do us apart.
索拉非尼的疗效通过改善生存期或降低死亡率来衡量。
The efficacy of sorafenib measured as the likelihood to improve survival or reduce mortality was of the same intensity as seen in western trials.
所有患者中位随访时间35.8个月，80例出现复发或转移，40例死亡，中位生存期未达到，中位无疾病生存期（DFS）为24.1个月。
After a median follow-up of 35.8 months, 80 patients experienced metastatic or recurrent tumors and 40 patients died. The median overall survival was not reached and the median DFS was 24.1 months.
结果死亡2例，皮瓣下积液6例，部分皮瓣或皮缘坏死2例，5年生存率92。
Results Two patients died, 6 experienced liquid under flap, and 2 suffered from flap or flap edge necrosis.
结果死亡2例，皮瓣下积液6例，部分皮瓣或皮缘坏死2例，5年生存率92。
Results Two patients died, 6 experienced liquid under flap, and 2 suffered from flap or flap edge necrosis.
应用推荐